大流行第 100 天内注册的 COVID-19 随机临床试验的招募和结果报告。
Recruitment and Results Reporting of COVID-19 Randomized Clinical Trials Registered in the First 100 Days of the Pandemic.
机构信息
Department of Clinical Research, University of Basel, Basel, Switzerland.
Meta-Research Innovation Center at Stanford, Stanford University, Stanford, California.
出版信息
JAMA Netw Open. 2021 Mar 1;4(3):e210330. doi: 10.1001/jamanetworkopen.2021.0330.
Abstract
This survey analysis of randomized clinical trials registered within 100 days of the first reported case of coronavirus disease 2019 assessed recruitment and results reporting.
摘要
这项对在首例 2019 年冠状病毒病报告后 100 天内注册的随机临床试验的调查分析评估了招募和结果报告情况。
相似文献
1
Recruitment and Results Reporting of COVID-19 Randomized Clinical Trials Registered in the First 100 Days of the Pandemic.大流行第 100 天内注册的 COVID-19 随机临床试验的招募和结果报告。
JAMA Netw Open. 2021 Mar 1;4(3):e210330. doi: 10.1001/jamanetworkopen.2021.0330.
2
Effects of rapid recruitment and dissemination on Covid-19 mortality: the RECOVERY trial.快速招募和传播对新冠死亡率的影响：RECOVERY 试验。
F1000Res. 2020 Aug 21;9:1017. doi: 10.12688/f1000research.25842.2. eCollection 2020.
3
Heart Failure Clinical Trial Operations During the COVID-19 Pandemic: Results From a Multicenter Survey.COVID-19大流行期间的心力衰竭临床试验操作：一项多中心调查结果
Circ Heart Fail. 2020 Sep;13(9):e007456. doi: 10.1161/CIRCHEARTFAILURE.120.007456. Epub 2020 Jul 23.
4
Preserving Clinical Trial Integrity During the Coronavirus Pandemic.在新冠疫情期间维护临床试验的完整性。
JAMA. 2020 Jun 2;323(21):2135-2136. doi: 10.1001/jama.2020.4689.
5
The COVID-19 pandemic: is our medicine still evidence-based?COVID-19 大流行：我们的医学仍然是基于证据的吗？
Ir J Med Sci. 2021 Feb;190(1):11-12. doi: 10.1007/s11845-020-02258-8. Epub 2020 May 28.
6
Geographical Representation of Low- and Middle-Income Countries in Randomized Clinical Trials for COVID-19.低收入和中等收入国家在 COVID-19 随机临床试验中的地域代表性。
JAMA Netw Open. 2022 Feb 1;5(2):e220444. doi: 10.1001/jamanetworkopen.2022.0444.
7
Therapy for Early COVID-19: A Critical Need.早期新冠病毒病的治疗：迫切需求。
JAMA. 2020 Dec 1;324(21):2149-2150. doi: 10.1001/jama.2020.22813.
8
Increase in recruitment upon integration of trial into a clinical care pathway: an observational study.纳入临床路径后试验招募人数增加：一项观察性研究。
BMJ Open Respir Res. 2021 Jul;8(1). doi: 10.1136/bmjresp-2021-000967.
9
COVID-19: Pitfalls in Offering Research Participation as Therapy in Clinical Settings.新型冠状病毒肺炎：在临床环境中将研究参与作为治疗手段的陷阱。
J Gen Intern Med. 2020 Nov;35(11):3359-3360. doi: 10.1007/s11606-020-06158-6. Epub 2020 Sep 3.
10
Tracheotomy Outcomes in 64 Ventilated COVID-19 Patients at a High-Volume Center in Bronx, NY.纽约布朗克斯一家大容量中心 64 例 COVID-19 患者行气管切开术的结局。
Laryngoscope. 2021 Jun;131(6):E1797-E1804. doi: 10.1002/lary.29391. Epub 2021 Jan 27.
引用本文的文献
1
In-hospital mortality outcomes of favipiravir in patients with moderate to severe COVID-19 infection: An emulated target trial using real-world data from the largest field hospital in Thailand.法匹拉韦治疗中度至重度新型冠状病毒肺炎感染患者的院内死亡结局：一项利用泰国最大野战医院真实世界数据的模拟目标试验
PLoS One. 2025 Jun 4;20(6):e0324903. doi: 10.1371/journal.pone.0324903. eCollection 2025.
2
A service-oriented approach to clinical trial recruitment for dementia and brain health: Methods and case examples of MyAlliance for Brain Health.一种面向痴呆症和脑健康临床试验招募的服务型方法：脑健康联盟（MyAlliance for Brain Health）的方法及案例
Alzheimers Dement (N Y). 2024 Jun 20;10(2):e12475. doi: 10.1002/trc2.12475. eCollection 2024 Apr-Jun.
3
Dissemination of Registered COVID-19 Clinical Trials (DIRECCT): a cross-sectional study.新冠肺炎临床试验注册信息传播度（DIRECCT）：一项横断面研究。
BMC Med. 2023 Nov 29;21(1):475. doi: 10.1186/s12916-023-03161-6.
4
Factors that impact on recruitment to vaccine trials in the context of a pandemic or epidemic: a qualitative evidence synthesis.大流行或传染病背景下疫苗试验招募的影响因素：定性证据综合。
Cochrane Database Syst Rev. 2023 Sep 1;9(9):MR000065. doi: 10.1002/14651858.MR000065.pub2.
5
Challenges and solutions in clinical research during the COVID-19 pandemic: A narrative review.2019年冠状病毒病大流行期间临床研究中的挑战与解决方案：一篇叙述性综述。
Health Sci Rep. 2023 Aug 6;6(8):e1482. doi: 10.1002/hsr2.1482. eCollection 2023 Aug.
6
External control arms: COVID-19 reveals the merits of using real world evidence in real-time for clinical and public health investigations.外部对照臂：新冠疫情揭示了在临床和公共卫生调查中实时使用真实世界证据的优点。
Front Med (Lausanne). 2023 Jul 6;10:1198088. doi: 10.3389/fmed.2023.1198088. eCollection 2023.
7
Identification of the ideal recruitment situation in pandemic research: learning from the RECOVERY trial in Northern England: a qualitative study.在大流行研究中确定理想的招募情况：从英格兰北部的 RECOVERY 试验中吸取经验教训：一项定性研究。
BMJ Lead. 2023 Jun;7(2):108-116. doi: 10.1136/leader-2021-000566. Epub 2022 Oct 23.
8
Characteristics and result reporting of registered COVID-19 clinical trials of Chinese and Indian traditional medicine: A comparative analysis.中国和印度传统医学注册的COVID-19临床试验的特征与结果报告：一项比较分析。
Front Med (Lausanne). 2023 Feb 17;10:1118269. doi: 10.3389/fmed.2023.1118269. eCollection 2023.
9
Hydroxychloroquine to prevent SARS-CoV-2 infection among healthcare workers: early termination of a phase 3, randomised, open-label, controlled clinical trial.羟氯喹预防医护人员感染 SARS-CoV-2：一项 3 期、随机、开放标签、对照临床试验的早期终止。
BMC Res Notes. 2023 Feb 28;16(1):22. doi: 10.1186/s13104-023-06281-7.
10
Competition for recruitment in SARS-CoV-2 Trials in the United States: a longitudinal cohort analysis.美国 SARS-CoV-2 临床试验中的招募竞争：一项纵向队列分析。
BMC Res Notes. 2022 Dec 12;15(1):368. doi: 10.1186/s13104-022-06263-1.
本文引用的文献
1
The worldwide clinical trial research response to the COVID-19 pandemic - the first 100 days.全球应对 COVID-19 大流行的临床试验研究——前 100 天
F1000Res. 2020 Oct 2;9:1193. doi: 10.12688/f1000research.26707.2. eCollection 2020.
2
Pooling Data From Individual Clinical Trials in the COVID-19 Era.汇总新冠疫情时代个体临床试验的数据。
JAMA. 2020 Aug 11;324(6):543-545. doi: 10.1001/jama.2020.13042.
3
Waste in covid-19 research.新冠疫情研究中的浪费现象。
BMJ. 2020 May 12;369:m1847. doi: 10.1136/bmj.m1847.
Zotero 插件